PXD068183 is an
original dataset announced via ProteomeXchange.
Dataset Summary
| Title | Vesicle-mediated mitochondrial clearance presents an actionable metabolic vulnerability in triple-negative breast cancer |
| Description | Selective autophagy of mitochondria is known to promote survival and progression of cancer cells in various malignancies, including triple-negative breast cancer (TNBC). Here, we investigate the essential metabolic adaptations that support mitochondrial quality control in cancer cells with the aim to uncover therapeutically actionable metabolic vulnerabilities. Using TNBC as a model system and an integrated approach of proteomics and untargeted and stable-isotope resolved metabolomics, together with functional experimental analyses, we detail a mitochondrial quality control mechanism, complementary to mitophagy, that is enabled by an onco-metabolic program of heightened extracellular sphingomyelin salvaging in TNBC coupled with extracellular vesicle (EV)-mediated intracellular clearance of mitochondrial damage. Targeting of this sphingolipid pathway in cancer cells via repurposing of eliglustat, a selective small molecule inhibitor of glucosylceramide synthase (UGCG), resulted in ceramide-mediated compensatory mitophagy and subsequent cancer cell death in vitro and attenuated tumor growth and prolonged overall survival at clinically achievable doses in an orthotopic syngeneic mouse models of TNBC as well as in human cell-line derived xenograft models. Our study defines a mechanism of aberrant sphingolipid metabolism that underlies an actionable metabolic vulnerability for anti-cancer treatment. |
| HostingRepository | PRIDE |
| AnnounceDate | 2025-09-30 |
| AnnouncementXML | Submission_2025-09-30_08:02:25.101.xml |
| DigitalObjectIdentifier | |
| ReviewLevel | Peer-reviewed dataset |
| DatasetOrigin | Original dataset |
| RepositorySupport | Unsupported dataset by repository |
| PrimarySubmitter | Yining Cai |
| SpeciesList | scientific name: Homo sapiens (Human); NCBI TaxID: 9606; |
| ModificationList | monohydroxylated residue; iodoacetamide derivatized residue |
| Instrument | Bruker Daltonics timsTOF series |
Dataset History
| Revision | Datetime | Status | ChangeLog Entry |
| 0 | 2025-09-08 07:30:59 | ID requested | |
| ⏵ 1 | 2025-09-30 08:02:25 | announced | |
Publication List
| Dataset with its publication pending |
Keyword List
| submitter keyword: Sphingolipids |
| Mitochondria |
| Autophagy |
| Extracellular Vesicles |
| Triple Negative Breast Cancer |
Contact List
| Johannes F. Fahrmann |
| contact affiliation | Assistant Professor, Clinical Cancer Prevention, University of Texas MD Anderson Cancer Center |
| contact email | JFFahrmann@mdanderson.org |
| lab head | |
| Yining Cai |
| contact affiliation | Software Developer |
| contact email | ycai4@mdanderson.org |
| dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/09/PXD068183 |
| PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD068183
- Label: PRIDE project
- Name: Vesicle-mediated mitochondrial clearance presents an actionable metabolic vulnerability in triple-negative breast cancer